Cargando…
Statistical considerations on implementing the MCP-Mod method for binary endpoints in clinical trials
The Multiple Comparison Procedure – Modelling (MCP-Mod) method was qaulified by regulatory agencies (e.g., EMA in 2014 and FDA in 2016) as an efficient statistical method for Phase 2 dose-finding studies when there is uncertainty about dose-response relationship. As this is a relatively new approach...
Autores principales: | Chen, Jingjing, Liu, Tina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451792/ https://www.ncbi.nlm.nih.gov/pubmed/32875139 http://dx.doi.org/10.1016/j.conctc.2020.100641 |
Ejemplares similares
-
Innovative considerations on a phase 2a dose-finding strategy using Bayesian methods and MCP-MOD
por: Bedding, Alun, et al.
Publicado: (2015) -
Statistical considerations in the design and analysis of non-inferiority trials with binary endpoints in the presence of non-adherence: a simulation study
por: Mo, Yin, et al.
Publicado: (2020) -
Binary surrogate endpoints in clinical trials from the perspective of case definitions
por: HAHN, ANDREAS, et al.
Publicado: (2021) -
Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies
por: Li, Yimei, et al.
Publicado: (2022) -
A retrospective analysis of conditional power assumptions in clinical trials with continuous or binary endpoints
por: Edwards, Julia M., et al.
Publicado: (2023)